Open Access

ARTICLE

Repurposing of FDA-Approved drugs to predict new inhibitors against key regulatory genes in Mycobacterium tuberculosis

XINJUN YANG¹, AFTAB ALAM², NAIYAR IQBAL³, KHALID RAZA^4,*

1 Department of Pediatrics, 3201 Hospital, Hanzhong, China
2 Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, India
3 Department of Computer Science and Information Technology, Maulana Azad National Urdu University, Hyderabad, India
4 Department of Computer Science, Jamia Millia Islamia, New Delhi, India

* Corresponding Author: Khalid Raza,